{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:06Z","timestamp":1791838146136,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072973"],"award-info":[{"award-number":["P30AG072973"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130423"],"award-info":[{"award-number":["P20 GM130423"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006727","name":"University of Kansas Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018033","name":"The University of Kansas Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.isci.2026.116079","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:58:49Z","timestamp":1779721129000},"page":"116079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ciclopirox reprograms effector responses and modulates Notch1 activation in activated human T cells"],"prefix":"10.1016","volume":"29","author":[{"given":"Aprajita","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debolina","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehak","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Fisette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Santana-Magal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"John A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Bossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-434X","authenticated-orcid":false,"given":"Scott J.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-7470","authenticated-orcid":false,"given":"Kalyani","family":"Pyaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116079_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0738-081X(91)90075-V","article-title":"Ciclopirox olamine: a hydroxypyridone antifungal agent","volume":"9","author":"Abrams","year":"1991","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.isci.2026.116079_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-4362.2001.01156.x","article-title":"Ciclopirox: an overview","volume":"40","author":"Gupta","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.isci.2026.116079_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-4362.42.s1.2.x","article-title":"Ciclopirox for the treatment of superficial fungal infections: a review","volume":"42","author":"Gupta","year":"2003","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.isci.2026.116079_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4103\/idoj.IDOJ_29_19","article-title":"Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal","volume":"10","author":"Sonthalia","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.isci.2026.116079_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41419-021-03836-z","article-title":"Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the \u03b3-secretase complex","volume":"12","author":"Weir","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.116079_bib6","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/MAO.0b013e318184f4a9","article-title":"Ototoxic effect of topical ciclopirox as an antimycotic preparation","volume":"29","author":"Baylancicek","year":"2008","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.isci.2026.116079_bib7","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/ijerph7072745","article-title":"Chelation in metal intoxication","volume":"7","author":"Flora","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.isci.2026.116079_bib8","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2009-03-209965","article-title":"Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells","volume":"114","author":"Eberhard","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116079_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7547\/0970195","article-title":"Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study","volume":"97","author":"Brenner","year":"2007","journal-title":"J. Am. Podiatr. Med. Assoc."},{"key":"10.1016\/j.isci.2026.116079_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jcdd10020052","article-title":"Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac Fibrosis","volume":"10","author":"Subbaiah","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.isci.2026.116079_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1574892816666210211090845","article-title":"Reposition of the Fungicide Ciclopirox for Cancer Treatment","volume":"16","author":"Huang","year":"2021","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.isci.2026.116079_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.apsb.2019.08.002","article-title":"Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent","volume":"10","author":"Feng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.116079_bib13","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/ijc.25255","article-title":"The antitumor activity of the fungicide ciclopirox","volume":"127","author":"Zhou","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2026.116079_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141299","article-title":"Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease","volume":"6","author":"Radadiya","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.116079_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.119.257972","article-title":"Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs","volume":"370","author":"Weir","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.isci.2026.116079_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41419-020-02868-1","article-title":"Correction: Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer","volume":"11","author":"Qi","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.116079_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12964-022-00847-x","article-title":"Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells","volume":"20","author":"Lu","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2026.116079_bib18","first-page":"887","article-title":"Targeting the Wnt\/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model","volume":"25","author":"Kim","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.isci.2026.116079_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.exphem.2013.04.012","article-title":"Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity","volume":"41","author":"Sen","year":"2013","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.isci.2026.116079_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.23640","article-title":"Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies","volume":"89","author":"Minden","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2026.116079_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102339","article-title":"ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy","volume":"53","author":"Fan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.116079_bib22","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.18632\/oncotarget.23164","article-title":"Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models","volume":"9","author":"Mihailidou","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.116079_bib23","article-title":"Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma","volume":"12","author":"Yin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.116079_bib24","article-title":"Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition \u03b2-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116079_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-4690-6-90","article-title":"Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A","volume":"6","author":"Hoque","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.isci.2026.116079_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106290","article-title":"Ciclopirox suppresses poxvirus replication by targeting iron metabolism","volume":"244","author":"Pant","year":"2025","journal-title":"Antiviral Res"},{"key":"10.1016\/j.isci.2026.116079_bib27","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.2174\/1381612822666160530151209","article-title":"Repositioning the Old Fungicide Ciclopirox for New Medical Uses","volume":"22","author":"Shen","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.isci.2026.116079_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1461-1244.2004.02380.x","article-title":"Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties","volume":"43","author":"Gupta","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.isci.2026.116079_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175156","article-title":"Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice","volume":"930","author":"Liang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2026.116079_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/08923973.2023.2231628","article-title":"Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt\/\u03b2-Catenin signaling pathway","volume":"45","author":"Zhou","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.isci.2026.116079_bib31","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.e16557","article-title":"Fosciclopirox clinical proof of concept in patients with nonmuscle invasive and muscle-invasive bladder cancer","volume":"40","author":"Weir","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116079_bib32","first-page":"2135","article-title":"Notch signaling at a glance","volume":"126","author":"Hori","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.isci.2026.116079_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0962-8924(97)01161-6","article-title":"The NOTCH receptor and its ligands","volume":"7","author":"Fleming","year":"1997","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2026.116079_bib34","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s00018-008-7586-4","article-title":"ADAM proteases: ligand processing and modulation of the Notch pathway","volume":"65","author":"Zolkiewska","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2026.116079_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.isci.2026.116079_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The Varied Roles of Notch in Cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2026.116079_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.isci.2026.116079_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1074-7613(04)00081-0","article-title":"Notch 1 signaling regulates peripheral T cell activation","volume":"20","author":"Eagar","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116079_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2010.01.004","article-title":"Notch signaling in the immune system","volume":"32","author":"Radtke","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116079_bib40","first-page":"279","article-title":"Precision medicine for human cancers with Notch signaling dysregulation (Review)","volume":"45","author":"Katoh","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.isci.2026.116079_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/30756","article-title":"Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain","volume":"393","author":"Schroeter","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116079_bib42","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1093\/nar\/gkac601","article-title":"Notch-dependent and -independent functions of transcription factor RBPJ","volume":"50","author":"Friedrich","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116079_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1074-7613(00)00009-1","article-title":"Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes","volume":"13","author":"Deftos","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116079_bib44","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190187","article-title":"Notch signalling in T cell homeostasis and differentiation","volume":"9","author":"Brandstadter","year":"2019","journal-title":"Open Biol."},{"key":"10.1016\/j.isci.2026.116079_bib45","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.1700070","article-title":"Novel TCR-Mediated Mechanisms of Notch Activation and Signaling","volume":"200","author":"Steinbuck","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2019.01.004","article-title":"The multifaceted role of Notch signal in regulating T cell fate","volume":"206","author":"Chiplunkar","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.isci.2026.116079_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nri1998","article-title":"Notch signalling during peripheral T-cell activation and differentiation","volume":"7","author":"Osborne","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.isci.2026.116079_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/vim.2019.0184","article-title":"The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease","volume":"33","author":"Kedzierska","year":"2020","journal-title":"Viral Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.isci.2026.116079_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2249.2002.02015.x","article-title":"Expansion of activated human na\u00efve T-cells precedes effector function","volume":"130","author":"Brenchley","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010113","article-title":"Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma","volume":"16","author":"Wan","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2026.116079_bib54","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41419-022-05456-7","article-title":"Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.116079_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(90)90210-M","article-title":"The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells","volume":"128","author":"Riddell","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2026.116079_bib56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116079_bib57","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.onc.1202016","article-title":"Cyclin D3: requirement for G1\/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation","volume":"17","author":"Bartkova","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.116079_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of Interleukin-2 in T Lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib59","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116079_bib60","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1038\/sj.onc.1203523","article-title":"The role of Stat5a and Stat5b in signaling by IL-2 family cytokines","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.116079_bib61","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2026.116079_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cyto.a.24304","article-title":"Kinetics of activation marker expression after in vitro polyclonal stimulation of chicken peripheral T cells","volume":"101","author":"Naghizadeh","year":"2022","journal-title":"Cytometry A"},{"key":"10.1016\/j.isci.2026.116079_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.116079_bib64","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.116079_bib65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The Roles of CD8(+) T Cell Subsets in Antitumor Immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2026.116079_bib66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","article-title":"Deficient T cell fate specification in mice with an induced inactivation of Notch1","volume":"10","author":"Radtke","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116079_bib68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.smim.2010.04.011","article-title":"Eliciting the T cell fate with Notch","volume":"22","author":"Sultana","year":"2010","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41598-022-26674-1","article-title":"Transcriptional regulation of Notch1 by nuclear factor-\u03baB during T cell activation","volume":"13","author":"Hwang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116079_bib70","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.4049\/jimmunol.0902432","article-title":"Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies","volume":"183","author":"Fiorini","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.isci.2026.116079_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2010.01.018","article-title":"Metabolism in T cell activation and differentiation","volume":"22","author":"Pearce","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib73","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.116079_bib74","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2026.116079_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027844","article-title":"Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing","volume":"6","author":"Ko","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116079_bib76","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","article-title":"Principles and therapeutic applications of adaptive immunity","volume":"187","author":"Chi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116079_bib77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.18632\/genesandcancer.135","article-title":"Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A","volume":"8","author":"Shen","year":"2017","journal-title":"Genes Cancer"},{"key":"10.1016\/j.isci.2026.116079_bib78","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3389\/fimmu.2018.02987","article-title":"Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act","volume":"9","author":"Kalia","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653605","article-title":"Control of T Cell Metabolism by Cytokines and Hormones","volume":"12","author":"Bishop","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-2776(08)60428-9","article-title":"Interferon-gamma: biology and role in pathogenesis","volume":"62","author":"Billiau","year":"1996","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib81","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1172\/JCI31860","article-title":"Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.116079_bib82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2026.116079_bib83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.isci.2026.116079_bib84","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1172\/JCI65477","article-title":"Blockade of individual Notch ligands and receptors controls graft-versus-host disease","volume":"123","author":"Tran","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.116079_bib85","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular metabolism regulates the differentiation and function of T-cell subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib86","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00424-016-1887-5","article-title":"Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes","volume":"468","author":"Mihailidou","year":"2016","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.isci.2026.116079_bib87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jac\/dki089","article-title":"Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans","volume":"55","author":"Sigle","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.116079_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00001","article-title":"Glucose metabolism regulates T cell activation, differentiation, and functions","volume":"6","author":"Palmer","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116079_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","article-title":"Metabolic switching and fuel choice during T-cell differentiation and memory development","volume":"249","author":"van der Windt","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2026.116079_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100902","article-title":"Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity","volume":"41","author":"Fitzel","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.isci.2026.116079_bib91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1525-1578(10)60494-1","article-title":"CyclinD1\/CyclinD3 ratio by real-time PCR improves specificity for the diagnosis of mantle cell lymphoma","volume":"6","author":"Jones","year":"2004","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.isci.2026.116079_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92941-2","article-title":"Activation of NF-\u03baB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2","volume":"11","author":"Su","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116079_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086790","article-title":"Identification of STAT5A and STAT5B target genes in human T cells","volume":"9","author":"Kanai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116079_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1477-7819-12-78","article-title":"Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment","volume":"12","author":"Yu","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.isci.2026.116079_bib95","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41380-024-02746-8","article-title":"Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes","volume":"30","author":"Bell","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.isci.2026.116079_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100845","article-title":"Isolation of polymorphonuclear neutrophils and monocytes from a single sample of human peripheral blood","volume":"2","author":"Cui","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.isci.2026.116079_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2026.104360","article-title":"Protocol for intranuclear Nrf2 detection in activated mouse, human, and Jurkat T cells by spectral flow cytometry","volume":"7","author":"Tripathi","year":"2026","journal-title":"STAR Protoc."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226014549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:42:15Z","timestamp":1791837735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226014549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2589004226014549"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116079","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ciclopirox reprograms effector responses and modulates Notch1 activation in activated human T cells","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116079"}}